Ilika’s Graeme Purdy on Project SiSTEM (LON:IKA)

Ilika plc

Ilika plc (LON:IKA) Chief Executive Officer Graeme Purdy caught up with DirectorsTalk for an exclusive interview to discuss their new collaboration – SiSTEM, how this differs from the HISTORY programme, production capacity, scaling up manufacturing capability, and the tech transfer deal with Cirtec.

Q1: IlIka announced a new collaborative program, codename SiSTEM, and that’s supported by a £2.7 million grant from the Automotive Transformation Fund. Could you just explain for us, though, the scope of the programme?

A1: The programme has got two very clear objectives. On the one hand, by the end of the programme, we will have developed an assembly line that will support the manufacturing of 1.5 megawatt hours per year of Goliath batteries, and we’re doing that together with MPAC. The second objective is to manufacture Ilika electrodes on the manufacturing line at UKBIC, the UK Battery Industrialisation Centre.

Both of these steps really are important milestones on the journey through increasing the manufacturing readiness of our product as it’s scaled up from the work that we’ve done in the lab, demonstrating that the product has certain features and benefits and moving towards a fully industrialised solution.

Q2: How is SiSTEM different from the HISTORY programme? That was the one that was funded by the Faraday Battery Challenge, and Ilika obviously commenced earlier this year.

A2: That’s absolutely right. The HISTORY programme is a product development programme in which we are optimising the properties and function of Goliath, whereas the SiSTEM grant really is all about manufacturing processes.

So, how do you take that product and then turn it into a process that is reproducible and can be scaled at a given price point.

Q3: Will the production capacity of Ilika be at the conclusion of this project?

A3: Yes, so by the end of the SiSTEM programme, we will have an installed capacity of about one and a half megawatt hours a year, which will be enough to allow us to manufacture round numbers, about 5000 pouch cells a year.

This is really the volume that we need in order to deliver samples, not only to our test programmes for further verification and validation, but also to our partners so the OEMs and tier ones that have shown interest in the product and are waiting for samples.

Q4: How is the company planning to scale up its manufacturing capability further?

A4: Well, it’s important to emphasise that Ilika has an asset light model, so what that means is that we will be working with scale up partners to actually increase the volume of manufacture to the industrial scale. Of course, we followed that model very successfully with the Stereax part of the business.

You’ll remember that earlier this year, we signed a tech transfer deal and a licensing deal with a company called Cirtec to transfer the Stereax technology across to the US to their large-scale manufacturing facility in Lowell, Massachusetts.

We have a similar business model for Goliath, we will manufacture prototype samples, demonstrate that the Goliath power cells have got the properties that are desirable by the automotive industry, and then we will transfer the technology through to a manufacturing partner, probably a tier one partner, who will then manufacture the product at scale for the OEMs.

Q5: You mentioned the tech transfer deal with Cirtec, how is that progressing now?

A5: That is firmly on track. Actually, Ilika have now transferred the majority of the equipment that is required by Cirtec to be able to manufacture the Stereax product to their facility. That equipment is starting to arrive in the US and is being installed at the moment. I think we’ve got one piece of equipment which is currently being disassembled and created, and then that will complete what we’re going to send over in order to get them started.

We’ll then be putting that equipment through a commissioning and qualification programme that’ll take us into next year as we start to run our first product lots and demonstrate that we can manufacture the quality of product that’s expected by our customers in the course of next year.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Search